Literature DB >> 18668576

The controversial role of tumor necrosis factor alpha in fibrotic diseases.

Jörg H W Distler1, Georg Schett, Steffen Gay, Oliver Distler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18668576     DOI： 10.1002/art.23645

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  38 in total

1.  Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma.

Authors:  Daniel Massó-Vallés; Toni Jauset; Erika Serrano; Nicole M Sodir; Kim Pedersen; Nesrine I Affara; Jonathan R Whitfield; Marie-Eve Beaulieu; Gerard I Evan; Laurence Elias; Joaquín Arribas; Laura Soucek
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

Review 2.  Immunotherapy of systemic sclerosis.

Authors:  Rebecca Manno; Francesco Boin
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

3.  Cell geometry dictates TNFα-induced genome response.

Authors:  Aninda Mitra; Saradha Venkatachalapathy; Prasuna Ratna; Yejun Wang; Doorgesh Sharma Jokhun; G V Shivashankar
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

4.  Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.

Authors:  Deborah E Citrin; Pataje G S Prasanna; Amanda J Walker; Michael L Freeman; Iris Eke; Mary Helen Barcellos-Hoff; Molykutty J Arankalayil; Eric P Cohen; Ruth C Wilkins; Mansoor M Ahmed; Mitchell S Anscher; Benjamin Movsas; Jeffrey C Buchsbaum; Marc S Mendonca; Thomas A Wynn; C Norman Coleman
Journal:  Radiat Res       Date:  2017-05-10       Impact factor: 2.841

5.  Exploring the prevalence of skin tears and skin properties related to skin tears in elderly patients at a long-term medical facility in Japan.

Authors:  Yuiko Koyano; Gojiro Nakagami; Shinji Iizaka; Takeo Minematsu; Hiroshi Noguchi; Nao Tamai; Yuko Mugita; Aya Kitamura; Keiko Tabata; Masatoshi Abe; Ryoko Murayama; Junko Sugama; Hiromi Sanada
Journal:  Int Wound J       Date:  2014-03-28       Impact factor: 3.315

Review 6.  Scleroderma therapy: clinical overview of current trends and future perspective.

Authors:  Afsha A Topal; Rachita S Dhurat
Journal:  Rheumatol Int       Date:  2012-08-03       Impact factor: 2.631

Review 7.  [Systemic sclerosis. Objectives for the treatment].

Authors:  B Maurer; M Walder; R E Gay; S Gay; O Distler
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

8.  Anti-TNFα alters the natural history of experimental Crohn's disease in rats when begun early, but not late, in disease.

Authors:  Phyllissa Schmiedlin-Ren; Laura J Reingold; Christopher S Broxson; Ahren C Rittershaus; Josh S Brudi; Jeremy Adler; Scott R Owens; Ellen M Zimmermann
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-25       Impact factor: 4.052

9.  Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register.

Authors:  W G Dixon; K L Hyrich; K D Watson; M Lunt; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2010-05-05       Impact factor: 19.103

10.  TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis.

Authors:  Clemens Duerrschmid; Jeffrey R Crawford; Erin Reineke; George E Taffet; Joann Trial; Mark L Entman; Sandra B Haudek
Journal:  J Mol Cell Cardiol       Date:  2013-01-18       Impact factor: 5.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.